J Korean Med Assoc.  2012 Jun;55(6):516-524. 10.5124/jkma.2012.55.6.516.

Differential diagnosis of acute diarrheal disorders in children

• Shim JO

• KMID: 2015649
• DOI: http://doi.org/10.5124/jkma.2012.55.6.516

Abstract

Acute diarrhea is one of the most common symptoms in children. Common causes and differential diagnosis are reviewed in this article. In children with suspicious diarrhea, one should consider whether the stool is normal variant or true diarrhea and in the case of true diarrhea, whether it is infectious or noninfectious diarrhea, particularly bacterial or viral infection; last, in the case of bacterial infection, whether antibiotics is needed or not. Rotaviruses and noroviruses are the most common causes in children with acute diarrhea. The seasonal distribution of rotavirus infection is changing. Epidemics of norovirus are increasing. The main symptom of norovirus infection in children is vomiting, unlike rotavirus infection. Bacterial infection is not a common cause. When a child shows bloody and mucoid diarrhea, the use of antibiotics should be considered if the patient is a young infant, is immunocompromised, or has toxic symptoms such as high fever, severe dehydration, or malnutrition. Clinical approaches focused on etiology can support the proper management and prediction of prognosis. Genetic epidemiology research is needed to monitor the efficacy of rotavirus vaccination and to develop a norovirus vaccine.

Keyword

Acute diarrhea; Child; Rotavirus; Norovirus; Anti-bacterial agents

MeSH Terms

Anti-Bacterial Agents
Bacterial Infections
Child
Dehydration
Diagnosis, Differential
Diarrhea
Fever
Humans
Infant
Malnutrition
Molecular Epidemiology
Norovirus
Organothiophosphorus Compounds
Prognosis
Rotavirus
Rotavirus Infections
Seasons
Vaccination
Vomiting
Anti-Bacterial Agents
Organothiophosphorus Compounds

Figure

• 

  Figure 1 Seasonal distribution of viral agents in children. a)The number in parenthesis after each virus gives the total number of positive cases. b)The number in parenthesis after each month gives the total number of the samples tested.

Reference

1. Mortality and global burden of disease (GBD) [Internet]. World Health Organization. 2008. cited 2012 May 17. Geneva: World Health Organization;Available from: http://www.who.int/gho/mortality_burden_disease/en.

2. Acute infectious agents laboratory surveillance reports [Internet]. Korea Centers for Disease Control and Prevention. 2012. cited 2012 May 17. Cheongwon: Korea Centers for Disease Control and Prevention;Available from: http://www.cdc.go.kr.

3. Hwang JB. Clinical approaches for diarrheal disorders in infancy and early childhood. 1999. Daegu: Choongwae Publishing.

4. Ahmed K, Batuwanthudawe R, Chandrasena TG, Mitui MT, Rajindrajith S, Galagoda G, Pun SB, Uchida R, Kunii O, Moji K, Abeysinghe N, Nishizono A, Nakagomi O. Rotavirus infections with multiple emerging genotypes in Sri Lanka. Arch Virol. 2010. 155:71–75.

5. Shim JO, Baek IH, Le VP, Ko EM, Seok WS, Uh Y, Kim JK, Ahn SY, Lee HS, Ryoo E, Shim SY, Song W, Lim I, Kim W. Molecular characterization of rotavirus diarrhea among children in South Korea: detection of an unusual G11 strain. Arch Virol. 2011. 156:887–892.

6. Shim JO, Son DW, Shim SY, Ryoo E, Kim W, Jung YC. Clinical characteristics and genotypes of rotaviruses in a neonatal intensive care unit. Pediatr Neonatol. 2012. 53:18–23.

7. Chung JY. Acute viral gastroenteritis: recent trends and updates. Korean J Pediatr Gastroenterol Nutr. 2007. 10:Suppl 1. 53–57.

8. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM. Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006. 354:23–33.

9. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, Lopez P, Macias-Parra M, Ortega-Barria E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavia-Ruz N, Salmeron J, Ruttimann R, Tinoco JC, Rubio P, Nunez E, Guerrero ML, Yarzabal JP, Damaso S, Tornieporth N, Saez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M. Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006. 354:11–22.

10. The Korean Pediatric Society. Guidelines of the vaccination. 2008. 6th ed. Seoul: Gwangmun.

11. Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, Negredo A, Buesa J, Schreier E, Reacher M, Brown D, Gray J, Iturriza M, Gallimore C, Bottiger B, Hedlund KO, Torven M, von Bonsdorff CH, Maunula L, Poljsak-Prijatelj M, Zimsek J, Reuter G, Szucs G, Melegh B, Svennson L, van Duijnhoven Y, Koopmans M. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet. 2004. 363:682–688.

12. Han TH, Kim CH, Chung JY, Park SH, Hwang ES. Emergence of norovirus GII-4/2008 variant and recombinant strains in Seoul, Korea. Arch Virol. 2011. 156:323–329.

13. Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, Estes MK, Graham DY, Opekun AR, Richardson C, Mendelman PM. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med. 2011. 365:2178–2187.

14. Schmidt W, Schneider T, Heise W, Weinke T, pple HJ, Stoffler-Meilicke M, Liesenfeld O, Ignatius R, Zeitz M, Riecken EO, Ullrich R. Stool viruses, coinfections, and diarrhea in HIVinfected patients Berlin Diarrhea/Wasting Syndrome Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. 13:33–38.

15. Lim HS, Min YS, Lee HS. Epidemiologic investigation on an outbreak of salmonellosis in Yeongcheon-si, 2004. J Prev Med Public Health. 2005. 38:457–464.

16. Kliegman RM, Behman RE, Jenson HB, Stanton BF. Nelson textbook of pediatrics. 2007. 18th ed. Philadelphia: Saunders.

17. Centers for Disease Control and Prevention (CDC). Outbreak of multidrug-resistant Salmonella enterica serotype Newport infections associated with consumption of unpasteurized Mexican-style aged cheese--Illinois, March 2006-April 2007. MMWR Morb Mortal Wkly Rep. 2008. 57:432–435.

18. Park MS, Kang YH, Lee SJ, Song CY, Lee BK. Characteristics of epidemic multidrugresistant Salmonella enterica serovar Typhimurium DT104 strains first isolated in Korea. Korean J Infect Dis. 2002. 34:1–8.

19. Moore JE, Corcoran D, Dooley JS, Fanning S, Lucey B, Matsuda M, McDowell DA, Megraud F, Millar BC, OMahony R, O'Riordan L, O'Rourke M, Rao JR, Rooney PJ, Sails A, Whyte P. Campylobacter. Vet Res. 2005. 36:351–382.

20. Rahman MJ, Sarker P, Roy SK, Ahmad SM, Chisti J, Azim T, Mathan M, Sack D, Andersson J, Raqib R. Effects of zinc supplementation as adjunct therapy on the systemic immune responses in shigellosis. Am J Clin Nutr. 2005. 81:495–502.

21. Kee VR. Clostridium difficile infection in older adults: a review and update on its management. Am J Geriatr Pharmacother. 2012. 10:14–24.